FDA

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

www.fda.gov

FDA RSS Channel

Display # 
Title Published Date
FDA approves new medication for dry eye disease 12 July 2016
FDA advances Precision Medicine Initiative by issuing draft guidances on next generation sequencing-based tests 08 July 2016
FDA targets unlawful internet sales of illegal prescription medicines during International Operation Pangea IX 10 June 2016
FDA approves first buprenorphine implant for treatment of opioid dependence 26 May 2016
FDA approves new treatment for inhalation anthrax 22 March 2016
FDA takes additional action to better understand safety of Essure, inform patients of potential risks 01 March 2016
FDA providing $2 million in new grants for natural history studies in rare diseases 29 February 2016
FDA seeks $5.1 billion total for FY 2017 10 February 2016
Califf, FDA top officials call for sweeping review of agency opioids policies 04 February 2016
FDA approves first drug to show survival benefit in liposarcoma 28 January 2016
FDA approves first drug to treat a rare enzyme disorder in pediatric and adult patients 08 December 2015
FDA approves Opdivo to treat advanced form of kidney cancer 24 November 2015
FDA approves new treatment for HIV 06 November 2015
FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa 19 October 2015
FDA approves new injectable drug to treat schizophrenia 09 October 2015
FDA approves Keytruda for advanced non-small cell lung cancer 05 October 2015
FDA approves first treatment for sexual desire disorder 19 August 2015
FDA takes action to protect consumers from potentially dangerous counterfeit medicines and devices sold online 03 July 2015
FDA approves anti-clotting drug Savaysa 15 January 2015
FDA warns consumers about fraudulent Ebola treatment products 14 August 2014

Most Popular Now

Pfizer completes acquisition of Ana…

Pfizer Inc. (NYSE:PFE) today announced that it has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of...

Read more

New antibiotic Zavicefta approved i…

AstraZeneca today announced that the European Commission (EC) has granted marketing authorisation for Zavicefta (ceftazidime-avibactam, previously known as CAZ AVI), a ne...

Read more

Novo Nordisk and Aarhus University …

Novo Nordisk and Aarhus University's Science and Technology faculty today signed a collaboration agreement to strengthen protein technology research and development. Unde...

Read more

AstraZeneca enters licensing agreem…

AstraZeneca today announced that it has entered into agreements that support its strategic focus on three main therapy areas; Respiratory, Inflammation and Autoimmunity, ...

Read more

Novartis adds bispecific antibodies…

Today Novartis announced that it has entered into a collaboration and licensing agreement with Xencor for the development of bispecific antibodies for treating cancer. Th...

Read more

How the federal government limits v…

The use of medical marijuana for millions of patients suffering from a wide range of health conditions and the subsequent therapeutic benefits has long been documented. T...

Read more

Bristol-Myers Squibb and PsiOxus Th…

Bristol-Myers Squibb Company (NYSE: BMY) and PsiOxus Therapeutics, Ltd. (PsiOxus) today announced an exclusive clinical collaboration agreement to evaluate the safety, to...

Read more

Bristol-Myers Squibb acquires Cormo…

Bristol-Myers Squibb Company (NYSE:BMY) and Cormorant Pharmaceuticals announced today that Bristol-Myers Squibb has acquired all of the outstanding capital stock of Cormo...

Read more

Nanotechnology and math deliver two…

Math, biology and nanotechnology are becoming strange, yet effective bed-fellows in the fight against cancer treatment resistance. Researchers at the University of Waterl...

Read more

Sanofi Pasteur signs research agree…

Sanofi and its vaccines global business unit Sanofi Pasteur announced today a Cooperative Research and Development Agreement with the Walter Reed Army Institute of Resear...

Read more

Laboratory drug trials could lead t…

A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland. Developed by international phar...

Read more

Pasta is not fattening, quite the o…

In recent years pasta gained a bad reputation: it will fatten you. This led lots of people to limit its consumption, often as part of some aggressive "do it yourself" die...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest World Pharma Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

© World Pharma News 2006 - 2016